Martin Nicholas to Antibodies, Monoclonal
This is a "connection" page, showing publications Martin Nicholas has written about Antibodies, Monoclonal.
Connection Strength
0.253
-
Neurocognitive function in patients with recurrent glioblastoma treated with bevacizumab. Neuro Oncol. 2011 Jun; 13(6):660-8.
Score: 0.063
-
Corticosteroid use in patients with glioblastoma at first or second relapse treated with bevacizumab in the BRAIN study. Oncologist. 2010; 15(12):1329-34.
Score: 0.061
-
Response as a predictor of survival in patients with recurrent glioblastoma treated with bevacizumab. Neuro Oncol. 2011 Jan; 13(1):143-51.
Score: 0.061
-
Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma. J Clin Oncol. 2009 Oct 01; 27(28):4733-40.
Score: 0.056
-
Rejection of fetal neocortical neural transplants by H-2 incompatible mice. J Immunol. 1987 Oct 01; 139(7):2275-83.
Score: 0.012